These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25282732)

  • 1. [Hepatocellular carcinoma associated with continuous and discontinuous application of nucleoside analogues in the treatment of chronic hepatitis B].
    Duan S; Bao Z; Yuan X; Liu M; Wang L; Xiao M
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):462-4. PubMed ID: 25282732
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
    Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
    Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Averting hepatocellular carcinoma in chronic hepatitis B with antiviral therapy: tipping the balance or not yet?
    Janssen HL; Arif A
    Gastroenterology; 2014 Jul; 147(1):24-6. PubMed ID: 24877866
    [No Abstract]   [Full Text] [Related]  

  • 4. Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues.
    Toyoda H; Kumada T; Tada T; Sone Y; Fujimori M
    J Vasc Interv Radiol; 2012 Mar; 23(3):317-22.e1. PubMed ID: 22265248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.
    Niro GA; Ippolito AM; Fontana R; Valvano MR; Gioffreda D; Iacobellis A; Merla A; Durazzo M; Lotti G; Di Mauro L; Andriulli A
    J Viral Hepat; 2013 Jul; 20(7):502-9. PubMed ID: 23730844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-year cumulative incidence of HCC development and treatment regimen in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment.
    Wang S; Fang S; Liu Y
    J Viral Hepat; 2021 Sep; 28(9):1333-1334. PubMed ID: 34051028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiology of HBV related hepatocellular carcinoma in Japan].
    Nishiguchi S; Tamori A; Kuroki T; Oka H; Tanaka T; Monna T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):673-9. PubMed ID: 12442466
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of chronic hepatitis B in children: an unresolved issue.
    Della Corte C; Nobili V; Comparcola D; Cainelli F; Vento S
    J Gastroenterol Hepatol; 2014 May; 29(5):912-9. PubMed ID: 24863185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma.
    Kim JH; Lee YS; Lee HJ; Yoon E; Jung YK; Jong ES; Lee BJ; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    J Clin Gastroenterol; 2011 Jan; 45(1):64-8. PubMed ID: 20535028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
    Lim YS; Han S; Heo NY; Shim JH; Lee HC; Suh DJ
    Gastroenterology; 2014 Jul; 147(1):152-61. PubMed ID: 24583062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
    Triolo M; Della Corte C; Colombo M
    Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of interferon therapy on incidence of cirrhosis and hepatocellular carcinoma in Thai patients with chronic hepatitis B.
    Tangkijvanich P; Thong-ngam D; Mahachai V; Kladchareon N; Suwangool P; Kullavanijaya P
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):452-8. PubMed ID: 11944697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed, evidence-based approach to the treatment of chronic Hepatitis B.
    Han SH; Durazo FA; Saab S; Tong MJ
    J Clin Gastroenterol; 2011 Mar; 45(3):259-66. PubMed ID: 20856136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.
    Bridges EG; Cheng YC
    Prog Liver Dis; 1995; 13():231-45. PubMed ID: 9224504
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection.
    Wen WH; Chang MH; Hsu HY; Ni YH; Chen HL
    J Pediatr; 2004 Mar; 144(3):397-9. PubMed ID: 15001956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
    Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
    J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.
    Wong GL; Chan HL; Chan HY; Tse PC; Tse YK; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Wong VW
    Gastroenterology; 2013 May; 144(5):933-44. PubMed ID: 23415803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives on chronic hepatitis B.
    Locarnini S; Thompson A
    Semin Liver Dis; 2013 May; 33(2):95-6. PubMed ID: 23749664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.